Biocompatible dialysis fluids for peritoneal dialysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Biocompatible dialysis fluids for peritoneal dialysis

Published:2018-10-26 Issue:10 Volume:2018 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Htay Htay¹,Johnson David W²³,Wiggins Kathryn J⁴,Badve Sunil V⁵,Craig Jonathan C⁶⁷,Strippoli Giovanni FM⁶⁸⁹¹⁰,Cho Yeoungjee²³

Affiliation:

1. Singapore General Hospital; Department of Renal Medicine; 20 College Street Singapore Singapore 169856

2. Princess Alexandra Hospital; Department of Nephrology; Ipswich Road Woolloongabba Queensland Australia 4102

3. University of Queensland; Brisbane Australia

4. The Alfred Hospital; Department of Renal Medicine; Prahan VIC Australia

5. St George Hospital; Department of Nephrology; Kogarah NSW Australia

6. The Children's Hospital at Westmead; Cochrane Kidney and Transplant, Centre for Kidney Research; Westmead NSW Australia 2145

7. Flinders University; College of Medicine and Public Health; Adelaide SA Australia 5001

8. University of Bari; Department of Emergency and Organ Transplantation; Bari Italy

9. Diaverum; Medical Scientific Office; Lund Sweden

10. Diaverum Academy; Bari Italy

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007554.pub3/epdf/full

Reference270 articles.

1. Low-GDP peritoneal dialysis fluid ('balance') has less impact in vitro and ex vivo on epithelial-to-mesenchymal transition (EMT) of mesothelial cells than a standard fluid;Bajo;Nephrology Dialysis Transplantation,2011

2. A randomized controlled trial to determine whether treatment with at neutral pH, low glucose degradation product dialysate (balance) prolongs residual renal function in peritoneal dialysis patients;Brown;Peritoneal Dialysis International,2006

3. Utility of urinary biomarkers in predicting loss of residual renal function: the balANZ trial;Cho;Peritoneal Dialysis International,2015

4. Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients;Cho;BMC Nephrology,2014

5. Economic evaluation of neutral-pH, low-glucose degradation product peritoneal dialysis solutions compared with standard solutions: a secondary analysis of the balANZ Trial;Howard;American Journal of Kidney Diseases,2015

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pressure induces peritoneal fibrosis and inflammation through CD44 signaling;Renal Failure;2024-07-31

2. Detections of Chemicals and Migratory Plastics in Peritoneal Dialysis Fluids;Indian Journal of Nephrology;2024-07-01

3. Peritoneal dialysis-related infections in elderly patients;Clinical and Experimental Nephrology;2024-06-25

4. Sterile inflammation of peritoneal membrane caused by peritoneal dialysis: focus on the communication between immune cells and peritoneal stroma;Frontiers in Immunology;2024-05-08

5. Maßnahmen zum peritonealen Langzeiterhalt;Nephrologie aktuell;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3